Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baliarda is a prominent Argentine pharmaceutical company founded in 1971, specializing in the development, manufacturing, and commercialization of high-quality branded generic medications. The company maintains a robust presence in the Latin American market, offering an extensive portfolio that covers critical therapeutic areas including cardiology, neurology, psychiatry, gastroenterology, and rheumatology. Baliarda operates advanced manufacturing facilities in Argentina that adhere to international Good Manufacturing Practices (GMP) standards, ensuring high-quality production of oral solids and other dosage forms. Known for iconic regional brands such as Alplax and Glioten, the company focuses on providing accessible healthcare solutions through continuous investment in pharmaceutical technology and professional medical education.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baliarda.